Time Course and Morphology of Vascular Effects Associated with Photodynamic Therapy

Schmidt-Erfurth, 1999, Confocal indocyanine green angiography with 3-dimensional topography. Results in choroid neovascularization (CNV), Ophthalmologe, 96, 797, 10.1007/s003470050499 Birngruber, 2000, Confocal laser scanning fluorescence topography, Graefes Arch Clin Exp Ophthalmol, 238, 559, 10.1007/s004179900059 Schmidt-Erfurth, 2001, Three-dimensional topographic angiography in chorioretinal vascular disease, Invest Ophthalmol Vis Sci, 42, 2386 Teschner, 2003, Characterization of leakage activity in exudative chorioretinal disease with three-dimensional confocal angiography, Ophthalmology, 110, 687, 10.1016/S0161-6420(02)01972-3 2001, Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration, Am J Ophthalmol, 131, 541, 10.1016/S0002-9394(01)00967-9 2001, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin, Arch Ophthalmol, 119, 198 Schmidt-Erfurth, 1994, Vascular targeting in photodynamic occlusion of subretinal vessels, Ophthalmology, 101, 1953, 10.1016/S0161-6420(13)31079-3 Schloetzer-Schrehardt, 2002, Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes, Graefes Arch Clin Exp Ophthalmol, 240, 748, 10.1007/s00417-002-0517-4 Michels, 2003, Sequence of early vascular events after photodynamic therapy, Invest Ophthalmol Vis Sci, 44, 2147, 10.1167/iovs.02-0604 Schmidt-Erfurth, 2002, Photodynamic effects on choroidal neovascularization and physiological choroid, Invest Ophthalmol Vis Sci, 43, 830 Saito, 1996, A study of serum protein fraction binding to indocyanine green (ICG) by combined method of immunoelectrophoresis and ICG fundus video system, Nippon Ganka Gakkai Zasshi, 100, 617 Chang, 1998, Histologic localization of indocyanine green dye in aging primate and human ocular tissues with clinical angiographic correlation, Ophthalmology, 105, 1060, 10.1016/S0161-6420(98)96008-0 Rogers, 2002, Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization, Am J Ophthalmol, 134, 566, 10.1016/S0002-9394(02)01566-0 Schmidt-Erfurth, 2002, Histopathological changes following photodynamic therapy in human eyes, Arch Ophthalmol, 120, 835 Gollnick, 2003, Role of cytokines in photodynamic therapy-induced local and systemic inflammation, Br J Cancer, 88, 1772, 10.1038/sj.bjc.6600864 Henderson, 2004, Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy in tumors, Cancer Res, 64, 2120, 10.1158/0008-5472.CAN-03-3513 Schmidt-Erfurth, 2003, Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3 and pigment epithelial-derived factor, Invest Ophthalmol Vis Sci, 44, 4473, 10.1167/iovs.02-1115 Aiello, 1994, Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, N Engl J Med, 331, 1480, 10.1056/NEJM199412013312203 Malecaze, 1996, Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy, Arch Ophthalmol, 112, 1476, 10.1001/archopht.1994.01090230090028 Kvanta, 1996, Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor, Invest Ophthalmol Vis Sci, 37, 1929 Spaide, 2003, Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization, Ophthalmology, 110, 1517, 10.1016/S0161-6420(03)00544-X Spaide, 2005, Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization, Ophthalmology, 112, 301, 10.1016/j.ophtha.2004.08.012 Augustin A, Schmidt-Erfurth U. Photodynamic therapy combined with intravitreal triamcinolone in photodynamic therapy of occult choroidal neovascularization. Am J Ophthalmol. In press. Gragoudas, 2004, Pegaptanib for neovascular age-related macular degeneration, N Engl J Med, 351, 2805, 10.1056/NEJMoa042760